Results from our content library
AI-Powered Search
Sign in to search for any topic in our content library — get answers, related past year questions, and practice MCQs on the topic.
Sign in to searchQDENGA Vaccine: India's First Approved Dengue Vaccine
Context
India's Central Drugs Standard Control Organisation (CDSCO) and the Drugs Controller General of India (DCGI) have granted marketing authorisation to QDENGA (TAK-003), making it the first dengue vaccine approved in India. Developed by Takeda Pharmaceutical (Japan), the vaccine is expected to become commercially available in India during the first half of 2027.
History of the Issue
Sign up free to read the full article
Free accounts include 5 articles every month across current affairs, state notes, subject notes and more — upgrade anytime for unlimited access.
QDENGA (TAK-003) is India's first approved dengue vaccine by CDSCO. Developed by Takeda, it protects against all four dengue serotypes and is safe for seropositive and seronegative individuals.
Keywords